PB2218: ASSESSMENT OF CYSTATIN C IN PEDIATRIC SICKLE CELL DISEASE AND B-THALASSEMIA AS A MARKER OF SUBCLINICAL CARDIOVASCULAR DYSFUNCTION: A CASE-CONTROL STUDY

PB2218: ASSESSMENT OF CYSTATIN C IN PEDIATRIC SICKLE CELL DISEASE AND B-THALASSEMIA AS A MARKER OF SUBCLINICAL CARDIOVASCULAR DYSFUNCTION: A CASE-CONTROL STUDY

Bibliographic Details
Main Authors:	M. Beshir, D. Hanna, N. Khalifa, E. Baz, A. Elhewala
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000851700.17626.11

Similar Items

2218
by: Hannah Fehlner-Peach
Published: (2017-09-01)

PB2218: CHILDHOOD MYELPROLIFERATIVE NEOPLASMS; A SINGLE CENTER EXPERIENCE
by: Hasanein Ghali, et al.
Published: (2023-08-01)

Urinary cystatin C as a marker of tubular dysfunction
by: Mijušković Zoran, et al.
Published: (2007-01-01)

The early-type galaxy population in Abell 2218
by: Ziegler, B, et al.
Published: (2001)

Assessment of Subclinical Renal Glomerular and Tubular Dysfunction in Children with Beta Thalassemia Major
by: Asmaa A. Mahmoud, et al.
Published: (2021-02-01)

Milestones in the history of thalassemia and sickle cell disease
by: Dimitris Loukopoulos
Published: (2014-12-01)

Markers of Subclinical Cardiovascular Disease in Patients with Adrenal Incidentaloma
by: Magdalena Szychlińska, et al.
Published: (2020-02-01)

Cystatin B, cathepsin L and D related to surrogate markers for cardiovascular disease in children.
by: Magnus Dencker, et al.
Published: (2017-01-01)

Herschel deep far-infrared counts through Abell 2218 cluster-lens
by: Altieri, B, et al.
Published: (2010)

Herschel deep far-infrared counts through Abell 2218 cluster-lens
by: Altieri, B, et al.
Published: (2010)

Biventricular dimensions and function in pediatric sickle-cell disease and thalassemia major patients without cardiac iron
by: Meloni Antonella, et al.
Published: (2013-01-01)

Significance of Cardiac Magnetic Resonance Feature Tracking of the Right Ventricle in Predicting Subclinical Dysfunction in Patients with Thalassemia Major
by: Karuna M. Das, et al.
Published: (2022-08-01)

5596737 RETINOPATHY IN EGYPTIAN PATIENTS WITH SICKLE CELL DISEASE
by: T.H. Hassan, et al.
Published: (2023-04-01)

Association of metabolic syndrome and electrocardiographic markers of subclinical cardiovascular disease
by: Theodora W. Elffers, et al.
Published: (2017-05-01)

Different patterns of myocardial iron overload by multislice T2* Cardiovascular MR as markers of risk for cardiac dysfunction in thalassemia major
by: Lombardo Massimo, et al.
Published: (2011-02-01)

Reactivation of fetal hemoglobin in thalassemia and sickle cell disease
by: Sandro Eridani, et al.
Published: (2014-09-01)

Cystatin C-derived estimated glomerular filtration rate in children with sickle cell anaemia
by: Hakeem Edun Babatunde, et al.
Published: (2023-11-01)

Cystatin C as an Early Marker of Renal Dysfunction in Patients with Cirrhosis of Liver: A Cross-sectional Study
by: Bidyut Bhuyan, et al.
Published: (2024-03-01)

Multiparametric Cardiac Magnetic Resonance Assessment in Sickle Beta Thalassemia
by: Laura Pistoia, et al.
Published: (2024-03-01)

Myocardial iron overload in sickle/thalassemia patients of Italian origin
by: Meloni Antonella, et al.
Published: (2013-01-01)

PB2231: RATIONALE FOR THE USE OF COMBINATION CHELATION THERAPY IN PATIENTS WITH THALASSEMIA SYNDROMES OR SICKLE CELL ANEMIA: A SYSTEMATIC LITERATURE REVIEW
by: A. Kattamis, et al.
Published: (2022-06-01)

Sleep Irregularity and Subclinical Markers of Cardiovascular Disease: The Multi‐Ethnic Study of Atherosclerosis
by: Kelsie M. Full, et al.
Published: (2023-02-01)

Evaluation of serum cystatin-C and netrin-1 as predictive biomarkers for renal injury in children with beta-thalassemia major
by: Ameer J Shwayel, et al.
Published: (2023-01-01)

THE INFLUENCE OF TOOL GEOMETRY OF FRICTION STIR WELDS ON MECHANICAL PROPERTIES AND MICROSTRUCTURE OF 2218-T72 ALUMINUM ALLOY
by: Qasim M. . Doos, et al.
Published: (2011-10-01)

Effect of Liquid Forging Pressure on Solubility and Freezing Coefficients of Cast Aluminum 2124, 2218 and 6063 Alloys
by: Vineet Tirth, et al.
Published: (2020-03-01)

Current status and developments in gene therapy for thalassemia and sickle cell disease
by: Evangelia Yannaki, et al.
Published: (2014-12-01)

α+Thalassemia Antagonizes the Malaria-protective Effects of Sickle-Cell Trait
by: Chanaki Amaratunga, et al.
Published: (2014-11-01)

Biomarker discovery of thalassemia and sickle-cell disease from blood peptidome
by: Dong, Xueming
Published: (2016)

Detection of subclinical myocardial dysfunction in cocaine addicts with feature tracking cardiovascular magnetic resonance
by: Alicia M. Maceira, et al.
Published: (2020-09-01)

Cardiovascular Calcification as a Marker of Increased Cardiovascular Risk and a Surrogate for Subclinical Atherosclerosis: Role of Echocardiography
by: Andrea Faggiano, et al.
Published: (2021-04-01)

Novel biochemical markers for the prediction of renal injury in beta-thalassemia major pediatric patients
by: A. J. Shwayel, et al.
Published: (2023-10-01)

Progressive mitochondrial dysfunction in cerebellar synaptosomes of cystatin B-deficient mice
by: Katarin Gorski, et al.
Published: (2023-05-01)

Subclinical Hypothyroidism and Cardiovascular Disease
by: Sunghwan Suh, et al.
Published: (2015-09-01)

Dry Sliding Tribological Behaviors of Electrodeposited Ni-GO/SiC Composite Coating on the 2218 Aluminum Alloy
by: Yutao Yan, et al.
Published: (2022-04-01)

The Relationship between Cardiovascular Risk Scores and Several Markers of Subclinical Atherosclerosis in an Asymptomatic Population
by: Ovidiu Mitu, et al.
Published: (2021-03-01)

Cystatin-c May Indicate Subclinical Renal Involvement, While Orosomucoid Is Associated with Fatigue in Patients with Long-COVID Syndrome
by: Laszlo Zavori, et al.
Published: (2023-02-01)

Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease
by: Annamaria Aprile, et al.
Published: (2022-05-01)

Molecular Genetic Characterization of β-Thalassemia and Sickle Cell Syndrome in the Albanian Population
by: Babameto-Laku A, et al.
Published: (2011-01-01)

Cardiovascular Biomarker Profiles in Obesity and Relation to Normalization of Subclinical Cardiac Dysfunction after Bariatric Surgery
by: Sanne M. Snelder, et al.
Published: (2022-01-01)

SPECIAL FEATURES OF CARDIOVASCULAR SYSTEM STATES IN PATIENTS WITH CORONARY ARTERY DISEASE AND SUBCLINICAL THYROID DYSFUNCTION
by: L. A. Panchenkova, et al.
Published: (2003-12-01)